ClinicalTrials.gov
public full text
Public Domain
Efficacy and Safety Clinical Trial of Intranasal AST-726 for the Prevention of Migraine
The purpose of this migraine prevention study is to evaluate the efficacy and safety of AST-726 in moderate to severe migraine patients at one of two doses compared to placebo and compared to a baseline period as measured by a reduction in the number of migraine days.
Conceptio Open Archive
Analyze & explore related research in Conceptio
Connect this record directly into your research workflow or AI agent. Explore citations across open repositories, query full text, and export structured proof bundles.
This document is indexed with metadata only: full text is not available in the archive for this record. Open the official source ↗
Related documents
- An Extension Study to Evaluate the Long-Term Safety and Tolerability of Ubrogepant in the Treatment of Migraine#885291
- Study of the Safety and Neuroprotective Capacity of Scp776 in Acute Ischemic Stroke#1058364
- Multiple Oral Administration of ASP7991 to Non-elderly Male Subjects#897489
- A Study to Evaluate the Immune Response to the ASP7373 and Its Safety in Healthy Adult Volunteers#426652
- Remote Ischaemic Conditioning in the Older Person and Effects on Dynamic Cerebral Autoregulation#1033040
Record · ID 1101872
Retrieved via Conceptio: every document is proof-bundled with source, license, and retrieval metadata.
Retrieved via Conceptio: every document is proof-bundled with source, license, and retrieval metadata.
Bring this data into your agent: Connect via MCP or API · 20 free credits to start · no card required
Read the Docs → · View CLI source on GitHub · Conceptio Open Knowledge Archive
Read the Docs → · View CLI source on GitHub · Conceptio Open Knowledge Archive